Physician profile
Edward J Killeen
NPI 1376578336
$1,074.58
in general payments reported to CMS, 2019-2025
14 companies · $154 in 2025
The $154 reported for 2025 was more than what a typical Geriatric Psychiatry provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $921 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $198.47 | 2024-2025 | |
| Idorsia Pharmaceuticals US INC | $164.33 | 2024 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $97.33 | 2024 | Rexulti |
| Axsome Therapeutics, INC. | $90.97 | 2024 | Auvelity |
| Neurocrine Biosciences, INC. | $86.88 | 2024-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $82.96 | 2024 | Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $74.82 | 2024 | Caplyta |
| Vanda Pharmaceuticals INC. | $54.36 | 2024-2025 | Fanapt, Hetlioz |
| Corium, LLC | $52.28 | 2024 | Azstarys |
| Teva Pharmaceuticals USA, INC. | $45.70 | 2024 | Austedo Xr |
| Almatica Pharma LLC | $45.49 | 2024 | Loreev Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $39.24 | 2024 | Trintellix |
| Lundbeck LLC | $27.33 | 2024 | Rexulti |
| Tms Neurohealth Centers INC. | $14.42 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Killeen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.